Discover 1,092 paid clinical trials in South Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Carolina has a wide range of paid research studies actively seeking both healthy volunteers and those with particular health conditions. Major hubs in Charleston, Columbia, and Greenville provide access to innovative treatments and top-quality medical care.
Filter
1
Filter results
Results: 1,092
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Moncton, Portland ME, Boston MA, Springfield MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase3, Recruiting
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa